Coversum N combi 5/1.25 compresse rivestite con film Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

coversum n combi 5/1.25 compresse rivestite con film

servier (suisse) sa - perindoprilum, indapamidum - compresse rivestite con film - perindoprilum argininum 5 mg corresp. perindoprilum 3.395 mg, indapamidum 1.25 mg, lactosum monohydricum 71.33 mg, magnesii stearas, maltodextrinum, silica colloidalis anhydrica, carboxymethylamylum natricum a corresp. natrium 0.1134 mg, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, pro compresso obducto. - ipertensione - synthetika

Coversum N combi 10/2.5 mg compresse rivestite con film Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

coversum n combi 10/2.5 mg compresse rivestite con film

servier (suisse) sa - perindoprilum, indapamidum - compresse rivestite con film - perindoprilum argininum 10 mg corresp. perindoprilum 6.79 mg, indapamidum 2.5 mg, lactosum monohydricum 142.66 mg, magnesii stearas, maltodextrinum, silica colloidalis anhydrica, carboxymethylamylum natricum a corresp. natrium 0.2268 mg, pellicule: glycerolum, hypromellosum, magnesii stearas, macrogolum 6000, e 171, pro compresso obducto. - ipertensione - synthetika

Perindopril-Indapamid-Mepha 5 mg/1.25 mg Compresse rivestite con film Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

perindopril-indapamid-mepha 5 mg/1.25 mg compresse rivestite con film

mepha pharma ag - perindoprilum, indapamidum - compresse rivestite con film - perindoprilum 3.4 mg ut perindoprilum natricum corresp. perindoprili tosilas 5 mg, indapamidum 1.25 mg, natrii tosilas, lactosum monohydricum 148.112 mg, maydis amylum, natrii hydrogenocarbonas, amylum pregelificatum, povidonum k 30, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, pro compresso obducto, natrium 0.43 mg. - ipertensione - synthetika

Perindopril-Indapamid-Mepha 2.5 mg/0.625 mg Compresse rivestite con film Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

perindopril-indapamid-mepha 2.5 mg/0.625 mg compresse rivestite con film

mepha pharma ag - perindoprilum, indapamidum - compresse rivestite con film - perindoprilum 1.7 mg ut perindoprilum natricum corresp. perindoprili tosilas 2.5 mg, indapamidum 0.625 mg, natrii tosilas, lactosum monohydricum 74.056 mg, maydis amylum, natrii hydrogenocarbonas, amylum pregelificatum, povidonum k 30, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, pro compresso obducto, natrium 0.21 mg. - ipertensione - synthetika

Perindopril-Indapamid-Mepha 10 mg / 2.5 mg Compresse rivestite con film Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

perindopril-indapamid-mepha 10 mg / 2.5 mg compresse rivestite con film

mepha pharma ag - perindoprilum, indapamidum - compresse rivestite con film - perindoprilum 6.8 mg ut perindoprilum natricum corresp. perindoprili tosilas 10 mg, indapamidum 2.5 mg, natrii tosilas, lactosum monohydricum 296.224 mg, maydis amylum, natrii hydrogenocarbonas, amylum pregelificatum, povidonum k 30, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, pro compresso obducto corresp. natrium 0.87 mg. - ipertensione - synthetika

COGYR Italija - italų - AIFA (Agenzia Italiana del Farmaco)

cogyr

ist.farm.biol.stroder s.r.l. - bisoprololo e tiazidi - bisoprololo e tiazidi

Cabometyx Europos Sąjunga - italų - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - agenti antineoplastici - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Cometriq Europos Sąjunga - italų - EMA (European Medicines Agency)

cometriq

ipsen pharma - cabozantinib - neoplasie della tiroide - agenti antineoplastici - trattamento di pazienti adulti con carcinoma midollare della tiroide midollare progressivo, non resecabile localmente avanzato o metastatico.

SPORANOX Italija - italų - AIFA (Agenzia Italiana del Farmaco)

sporanox

janssen cilag s.p.a. - itraconazolo - itraconazolo

TRIASPORIN Italija - italų - AIFA (Agenzia Italiana del Farmaco)

triasporin

italfarmaco s.p.a. - itraconazolo - itraconazolo